+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intrahypothalamic microinfusion of corticotropin-releasing factor elevates blood glucose and free fatty acids in rats



Intrahypothalamic microinfusion of corticotropin-releasing factor elevates blood glucose and free fatty acids in rats



Journal of the Autonomic Nervous System 24(1-2): 87-95



Three experiments examined whether intrahypothalamic microinfusions of corticotropin releasing factor (CRF) can affect circulating levels of the metabolic fuels, glucose and free fatty acids. Infusions of CRF into the paraventricular nucleus dose-dependently increased serum glucose levels; greater increases were seen in acute than in chronic preparations. The greater effectiveness could not be accounted for by anesthetization per se. CRF infusion into the ventromedial nucleus did not affect serum glucose. Infusions into both sites, however, significantly increased serum free fatty acids. Neither glucose nor free fatty acids were altered by infusions into the lateral hypothalamus or the caudate-putamen. These data suggest that the previously identified CRF binding sites and CRF neuronal terminals in the paraventricular and ventromedial nuclei may be involved in the central regulation of metabolic fuel release. Additionally, it appears that the importance of CRF in the paraventricular nucleus in regulating serum glucose may be greater under some conditions than others.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040489650

Download citation: RISBibTeXText

PMID: 3264840

DOI: 10.1016/0165-1838(88)90139-7


Related references

Intracranial microinfusion of pancreastatin elevates blood glucose, free fatty acids, and corticosterone in rats. Brain Research 485(2): 251-257, 1989

Intracranial microinfusion of pancreastatin elevates blood glucose free fatty acids and corticosterone in rats. Society for Neuroscience Abstracts 14(1): 541, 1988

Intrahypothalamic corticotropin-releasing factor elevates gastric bicarbonate and inhibits stress ulcers in rats. American Journal of Physiology 258(1 Pt 1): G152-G157, 1990

Intrahypothalamic microinfusion of corticotropin-releasing factor inhibits gastric acid secretion but increases secretion volume in rats. Brain Research 411(1): 156-161, 1987

Microinjection of bombesin into midline thalamic nuclei elevates blood glucose, free fatty acids, and corticosterone in rats. Society for Neuroscience Abstracts 18(1-2): 1427, 1992

Bombesin microinfusion into the rat hypothalamic paraventricular nucleus increases blood glucose free fatty acids and corticosterone. Brain Research 478(1): 47-58, 1989

The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats. Endocrinology 118(6): 2390-2394, 1986

Glucose tolerance factor reduces blood glucose and free fatty acids levels in diabetic rats. Journal Of Inorganic Biochemistry. 49(2): 123-128, 1993

Electrocortical power spectrum changes induced by microinfusion of corticotropin-releasing factor into the locus coeruleus in rats. Functional Neurology 7(5): 407-412, 1992

Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats. Brain Research. 644(1): 101-108, 1994

Tissue corticotropin releasing factor an extrahypothalamic corticotropin releasing factor in the peripheral blood of stressed rats. Neuroendocrinology5: 225-235, 1973

Microinfusion of corticotropin-releasing factor into the locus coeruleus increases ceco-colonic myoelectric activity and LC neuronal activity simultaneously in anaesthetized rats. Gastroenterology 112(4 Suppl. ): A790, 1997

Intrahypothalamic neuroendocrine actions of corticotropin-releasing factor. Ciba Foundation Symposium 172: 151-69; Discussion 169-72, 1993

Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats. Brain Research 900(2): 177-185, 2001

Effects of ganglionic blocking drugs on blood glucose, amino acids, free fatty acids, free fatty acids and catecholamines at exercise in man. Acta Physiologica Scandinavica 64(4): 439-447, 1965